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Spatial and spatio‑temporal epidemiological
approaches to inform COVID‑19 surveillance
and control: a review protocol
Julius Nyerere Odhiambo1* and Carrie B. Dolan1,2

Abstract
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that cause coronavirus
disease 2019 (COVID-19) have afflicted millions worldwide. Understanding the underlying spatial and temporal
dynamics can help orient timely public health policies and optimize the targeting of non-pharmaceutical interventions and vaccines to the most vulnerable populations, particularly in resource-constrained settings. The review
systematically summarises important methodological aspects and specificities of spatial approaches applied to
COVID-19 in Africa.
Methods: Thematically selected keywords will be used to search for refereed studies in the following electronic databases PubMed, SCOPUS, MEDLINE, CINHAL, and Coronavirus Research Database from January 2020 to February 2022.
Two independent reviewers will screen the title, abstracts, and full texts against predefined eligibility criteria based
on the study’s characteristics, methodological relevance, and quality. The Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) 2020 procedures will be adhered to during the reporting process.
Discussion: COVID-19 modeling remains in its infancy, and research is needed to characterize uncertainty and validate various modeling regimes appropriately. It is anticipated that the review will aid spatial, spatio-temporal modeling decisions necessary for mitigating the current and future pandemics.
Systematic review registration: CRD42021279767
Keywords: Spatial, Spatio-temporal, Geospatial modeling,
COVID-19, Africa

Background
The rapid and devastating spread of the novel COVID19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen was first
discovered in Wuhan, Hubei Province, China, in the latter
part of 2019. COVID-19 continues to spread worldwide
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and has 234 million confirmed cases, and more than
4.8 million deaths have been reported worldwide. In
Africa, 9.1 million confirmed cases and 173,480 deaths
had been reported as of June 30, 2022 [1]. Its spread
has led to a dual health and economic burden resulting
in a substantial cost. The International Monetary Fund
(IMF) estimated a $ 20 trillion increase in government
debt between September 2019 to September 2020 [2]. In
mitigating this burden, governments have realigned their
healthcare services (cutting down routine testing of other
diseases, regulating elective surgeries, and limiting access
to non-urgent circumstances) and resources, depriving
the most vulnerable populations of essential medical services [3–5].
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Although the pandemic continues to overwhelm
health systems globally, Africa remains disproportionately affected, with more cases and deaths being
reported [6]. The disproportionate spread of COVID-19
across and within countries in Africa has not followed
a homogenous pattern. The heterogeneity is attributed to a country’s ability to prevent, detect and mount
response strategies [7–9]. This has been exacerbated
by incomplete documentation on COVID-19 cases and
deaths across the continuum of care [10] due to inefficient and unreliable disease surveillance systems, scarce
critical care resources, grossly underfunded and inadequate healthcare facilities, and insufficient training of
healthcare workers [11–13]. Additionally, its interaction with poverty-related non-communicable diseases
(NCDs) has led to adverse medical outcomes/attributable deaths that cannot be fully quantified [14–16].
Furthermore, the attributed burden remains affected
by the unacceptable inequalities in vaccine access and
rollout, putting at risk high-risk groups and healthcare
workers [12, 17]. Amidst these challenges, concerns
about the ability of African countries to achieve the
United Nations sustainable development goals (SDGs)
continue to be raised [18].
As more transmissible variants continue to spread,
driven in part by high human mobility, vaccine hesitancy,
low rates of mask utility, supply chain constraints, and
distribution inequalities, there is an urgent need of routine surveillance so as to obtain epidemiologically meaningful dynamics at relevant thresholds [13, 19]. Amidst
this need, diverse approaches have been employed to
unmask the trends and drivers of COVID-19 since its
declaration as a global pandemic. However, the utility of
spatial and spatio-temporal models has become more relevant and greatly improved the estimation of COVID-19
fine-scale risk [13]. These models have been sustained
by the enhanced computational ability creating an ideal
environment for identifying and visualizing the regional
and global trends of COVID-19 risk. The uptake of these
models has contributed to informed and timely public decision-making enabling the optimal allocation of

scarce resources, effective control, and containment initiatives, particularly in areas where variants are circulating.
Over the past 2 years, there has been an increase in
the literature regarding COVID-19 modeling in space
and time [20–23]. However, substantial uncertainty and
diverging methodologies of estimation and forecasting
have resulted in essential differences in the projections
and inference. There have been an ongoing concerns
about the availability and quality of the data that have
been used to generate critical metrics for quantifying the
progress made. This review seeks to appraise the data
sources and assess the modeling covariates and methodological rigor of studies employing spatial and spatiotemporal methods. The review can potentially enhance
the framework of infectious disease modeling, which
is essential for informing modeling decisions for future
pandemics in Africa.

Methods
Study registration and protocol

This review has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO
Reference: CRD42021279767). The review will also follow the reporting guidelines outlined in the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement (PRISMA 2020) [24] in its procedures
to enhance its rigor (Additional file 1).
Search strategy

In consultation with a librarian at William & Mary
Libraries, a rigorous, phased, and transparent process
will be undertaken to search for relevant studies, iteratively select eligible studies, and extract data from the
eligible studies. The relevant studies will be searched
using the following bibliographic databases, namely PubMed, SCOPUS, MEDLINE via Proquest, CINHAL via
EBSCOhost, and Coronavirus Research Database using
iterated search terms (Additional file 2). In order to
improve the comprehensiveness of the search, thematic
keywords will be funneled using Boolean operators, and
a combination of medical sub-headings (MeSH) will be

Table 1 Preliminary search string
Theme

Search string

COVID-19

(Betacoronavirus OR Betacoronaviruses), (Corona Virus OR Corona Viruses OR Coronavirus
OR Coronaviruses), (COVID OR COVID19 OR Covid-19 ), (CoV OR CoV2 OR HCoV-19 OR
nCoV OR 2019nCoV), (Severe Acute Respiratory Syndrome CoV OR severe acute respiratory syndrome coronavirus 2 OR SARS CoV 2 OR SARS-CoV-2 OR SARSCoV OR SARS-CoV
OR SARS2)

Model

Spati* OR geospatial OR space-time OR geographic OR mapping OR geospatial OR cluster

Location

Africa
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used and modified where necessary for each database
(Table 1). The snowball technique will be used to manually trace relevant studies in the list of references of the
eligible studies up to the point of saturation (i.e., no new
information emerged from subsequent articles manually searched). Gray literature will also be searched via
Google Scholar, and authors will be contacted for any
missing publications. After that, eligible studies will be
imported into RefWorks management software. Considering that on January 30, 2020, the World Health Organization officially declared COVID-19 a Public Health
Emergency of International Cancer [25], the literature
search will be limited to original studies published from
January 30, 2020 to February 2022 (Fig. 1).
Inclusion and exclusion criteria

A calibration exercise will ensure that only the correct
studies are included and that relevant study information
is consistently and accurately captured. This approach
improves the methodological rigor and will involve two
independent reviewers independently screening the title
and abstract of a random sample comprising 5% of the
studies. Studies will be eligible for review if they apply
one or more of the following spatial or spatio-temporal
analyses: exploration (using statistical tools to monitor trends), visualization (cluster analysis to quantify the

Fig. 1 PRISMA 2020 flow diagram

Page 3 of 6

geographic variation), and modeling (utilizing data to
explore COVID-19 risk factors and develop space-time
predictive models). We define a spatial model to explicitly
incorporate a geographic index for a given area/observations, whereas a temporal model will include a time index
(Table 2).
Studies will be excluded if their abstract or full text is
not available. Articles that are not peer-reviewed, such as
letters, editorials, comments, book/book sections, conference proceedings, or conceptual papers without findings; studies that did not focus on COVID-19; or did not
use GIS or geospatial techniques will also be ineligible
for inclusion. Experimental design studies, case series/

Table 2 Study inclusion criteria
Criteria

Description

Study type

Original peer-reviewed journal
article utilizing spatio-temporal
modeling approaches

Analytical approach

Spatial and spatio-temporal model.

Context

Geography: Africa
Language: no language restriction
Time frame: all publications from
January 30, 2020 to February 2022
will be included.
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reports, and studies on the genetic characterization of
COVID-19 will also be excluded.
The review team will resolve emerging discrepancies
until a consensus is reached. If consensus is not reached,
an independent arbitrator will be consulted for possible inclusion or exclusion. The eligibility criteria will be
modified if a kappa statistic lower than 50% is observed
between the reviewers, indicating low agreement.
Data abstraction

Using a predesigned online abstraction form, two reviewers will independently and iteratively abstract data on a
random sample of 10 articles (i.e., reading the full text
of each article and extracting the relevant information).
Emerging discordance between the reviewers concerning information extracted will be resolved by consensus
among the reviewers and by discussions with a third
reviewer. For each eligible study, the following information will be extracted (Table 3):
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i. Bibliographic information (author, year, country of
origin, spatial and temporal resolution)
ii. Study objective (s) (primary and secondary)
iii. Data sources and modeling covariates
iv. Analytic approach(es) (assumptions, frameworks,
cluster detection techniques, model validity test,
statistical software)
v. Results and discussions (Findings, study limitations, implications for future research)

Quality appraisal and risk of bias assessment

The review quality appraisal will be independently done
by two reviewers, who will outline the strengths and
weaknesses of each study using an adopted tool for
assessing quality [26, 27]. This tool will comprise 8-point
scoring criteria used to determine the quality of the
individual studies based on their study objectives, data
source, model validity, results, and conclusions. Four
broad categories will, namely: very high (> 13), high

Table 3 Data abstraction form
1. Bibliographic information
• Study ID
• Author, year
• Country
• Article title
• Language study period (start-end)
• Data source (medical records, multiple sources, others)
• Type of publication (Journal article, book chapter, grey literature).
• Data sources
• Study population/spatial unit (Household, national, province, district facility, census tract, other)
2. Aims
Study aims and objectives (primary and secondary)
3. Methodology
• Visualization techniques
• Cluster detection techniques
• Covariate(s) selection
• Spatial-temporal modelling approach
4. Results (does the paper report data relating to the following?)
Key findings
Unexpected results
5. Discussion
Key findings
Unexpected results
Modeling gap(s)
Limitations
6. Conclusions and recommendations
Modeling issues requiring further attention
Suggestions for improved analytical approaches for future studies

Odhiambo and Dolan Systematic Reviews

(2022) 11:141

(11–13), medium (8–10), and low (< 8), will be used to
assess the overall quality level of individual studies. Additionally, screening questions/criteria will guide the scoring process, ranging from 0 (poor) to 2 (good) on each
criterion (Additional file 3: Table S1).
Data synthesis and analysis

This phase will involve three distinct steps: analysis,
reporting, and interpreting the review findings. Thematic
content analysis will cluster studies based on their spatiotemporal methodological approaches, spatial and temporal resolution, data sources, and modeling approaches to
identify the dominant findings and make generalizations.
Descriptive summary tables will assess studies based on
their geographic location, publication year, data sources,
visualization, modeling approaches, and covariates.
Results will be reported based on the review objectives,
with the practical implications for policy and modeling
practices discussed. The current gaps in the spatio-temporal modeling of COVID-19 will also be outlined to
guide future research.

Discussion
Africa’s COVID-19 response strategy has mainly been
premised on the World Health Organization (WHO)
lead Covax Facility, which set an ambitious target of fully
vaccinating 20% of the African population by December,
2021 [28]. To achieve this target, the WHO advocates for
local, precise, and targeted distribution of vaccines and
non-pharmaceutical interventions based on principled
predictions at relevant thresholds. Over the past 2 years,
massive research about COVID-19 has been made available shifting and improving our understanding on the control and treatment options available. In particular, data
science tools and robust modelling appropriate have been
employed to better understand the trajectory of COVID19 and its attributable factors in space and time. These
models have incorporated diverse data sources, covariates and methodology to visualize and describe spatial
distributions, identify clusters, and determine patterns
of spatial association. Our review will identify knowledge
gaps, provide practical insights, help clarify complex and
multi-component spatial and spatio-temporal methods,
and enhance evidence-based practice and decision-making. Additionally, the review will provide valuable insight
to support future bibliographic queries and serve as a
resource for outlining the evolution of modeling tools in
a major global pandemic. It potentially will offer helpful
information specifically on how African countries collect
and report data in an era of pandemic health policying.

Page 5 of 6

Anticipated challenges

We foresee potential challenges relating to our systematic
review. First, our search strategy might yield more articles than we might expect. To mitigate this, we will work
closely with an information specialist at William & Mary
Libraries to ensure that the scope is manageable. Secondly, categorizing and appraising methods accurately
and exhaustively might be a challenge. However, we
intend to engage with stakeholders with in-depth subject
knowledge of COVID-19 modeling to receive feedback
important for the review.

Conclusion
The continuous spread of COVID-19, particularly in
unvaccinated populations in Africa, threatens to choke
progress made in fighting the pandemic. As high and
upper-middle-income countries ease mandates, the risk
of global resurgence remains due to the significant disparity in vaccine distribution, particularly in Africa.
There is an urgent need to increase equitable access
to vaccination and the pace of vaccination. This can be
done if policymakers make inferences based on reliable
data sources and robust statistical methodology to mitigate the pandemic. By outlining the main methodological
approaches used to quantify progress, the results from
this review can expand our current understanding of the
etiology of COVID-19, orient resource allocation, monitor healthcare access, and plan for effective interventions
in Africa and other resource-constrained settings.
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